203 results
Page 8 of 11
8-K
EX-99.1
3flxomj83787hm
9 Oct 14
Bio-Path Holdings Successfully Completes Cohort 6 of Phase I Clinical Trial Evaluating Liposomal Grb-2 in Blood Cancers
12:00am
8-K
EX-10.1
1j8a30fm36ly
18 Apr 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
lv17ku0lm1xdq
2 Apr 14
Bio-Path Holdings Reports Fiscal Year 2013
12:00am
424B5
jynbfzfrhb9w
21 Jan 14
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
910fg25
21 Jan 14
Bio-Path Holdings, Inc. to Raise $10 Million in Registered Direct Offering
12:00am
424B5
y58es71r50bx7fw8lqa5
17 Jan 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
jffer8jhntk xd
10 Dec 13
Preliminary Results from Bio-Path Holdings’ Phase I Clinical Trial
12:00am
8-K
EX-99.1
sjok5lur
18 Nov 13
Bio-Path Holdings Reports Third Quarter 2013
12:00am
8-K
EX-99.1
xlgeem
15 Aug 13
Bio-Path Holdings Reports Second Quarter 2013
12:00am
8-K
EX-99.1
ghzl8
7 Jun 13
Other Events
12:00am
8-K
EX-99.1
o2ppdn 31
4 Apr 13
Bio-Path Holdings Reports Fiscal Year 2012
12:00am